Announce Date | 04/25/2025 |
EPS Normalized Actual | $0.23 In Line |
EPS GAAP Actual | $0.23 In Line |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.29811 |
EPS GAAP Estimate | $0.29811 |
Revenue Estimate | $1.816735B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.6 | 8.68 | 1.55931 | 1.64998 | 1 |
Dec 2028 | 1.775 | 7.83 | 1.74737 | 1.80254 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0 | -0.27968 | 0B | -INF% | -1777.36M |
FQ4 2024 (Dec 2024) | 0.736 | 0.736 | 0B | -INF% | 0M |
FQ3 2024 (Sep 2024) | 0 | 0 | -0.0007B | 245842.86% | -0.7M |
FQ2 2001 (Jun 2001) | -0.0108 | -0.0108 | 1.7439B | 100% | 1743.9M |
FQ4 2017 (Dec 2017) | -2.84 | -2.84 | 0.7297B | 100% | 729.7M |
FQ2 2024 (Jun 2024) | 0.14 | 0.14 | 1.7028B | 100% | 1702.8M |
FQ1 2024 (Mar 2024) | 0.0891 | 0.0891 | 1.6798B | 100% | 1679.8M |
FQ4 2023 (Dec 2023) | 0.15 | 0.15 | 1.7228B | 100% | 1722.8M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.29811
Consensus Revenue Estimates
1.816735B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.32741 | -- | 0.31956 | 0.33199 | 5 |
FQ2 2027 (Jun 2027) | 0.31625 | -- | 0.30867 | 0.32067 | 5 |
FQ1 2027 (Mar 2027) | 0.30061 | -- | 0.29341 | 0.30481 | 5 |
FQ4 2026 (Oct 2026) | 0.36324 | -- | 0.35571 | 0.37212 | 5 |
FQ3 2026 (Jul 2026) | 0.34206 | -- | 0.33497 | 0.35042 | 5 |
FQ2 2026 (Jun 2026) | 0.34206 | -- | 0.33567 | 0.34813 | 5 |
FQ1 2026 (Mar 2026) | 0.3 | -- | 0.2944 | 0.30532 | 11 |
FQ4 2025 (Oct 2025) | 0.32011 | -129.92 | 0.31347 | 0.32794 | 11 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.79B | -- | 1.76B | 1.81B | 6 |
FQ2 2027 (Jun 2027) | 1.79B | -- | 1.76B | 1.81B | 6 |
FQ1 2027 (Mar 2027) | 1.74B | -- | 1.71B | 1.76B | 6 |
FQ4 2026 (Oct 2026) | 1.94B | -- | 1.91B | 1.98B | 8 |
FQ3 2026 (Jul 2026) | 1.92B | -- | 1.89B | 1.95B | 5 |
FQ2 2026 (Jun 2026) | 1.92B | -- | 1.89B | 1.94B | 5 |
FQ1 2026 (Mar 2026) | 1.87B | -- | 1.85B | 1.9B | 5 |
FQ4 2025 (Oct 2025) | 1.85B | -- | 1.82B | 1.88B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
5
Revenue # of Misses
2
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.27968 | 0 | -0.27968 | -INF% |
FQ4 2024 (Dec 2024) | 0.736 | 0.736 | 100% | |
FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
FQ2 2001 (Jun 2001) | -0.0108 | -0.0108 | 100% | |
FQ4 2017 (Dec 2017) | -2.84 | -2.84 | 100% | |
FQ2 2024 (Jun 2024) | 0.14 | 0.14 | 100% | |
FQ1 2024 (Mar 2024) | 0.0891 | 0.0891 | 100% | |
FQ4 2023 (Dec 2023) | 0.15 | 0.15 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.78B | $0B | $-1777.36M | -INF% |
FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
FQ3 2024 (Sep 2024) | $0B | $-0B | $-0.7M | 100% |
FQ2 2001 (Jun 2001) | $0B | $1.74B | $1743.9M | 100% |
FQ4 2017 (Dec 2017) | $0B | $0.73B | $729.7M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.7B | $1702.8M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.68B | $1679.8M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.72B | $1722.8M | 100% |